First Time Loading...
S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 28.35 CNY -1.25% Market Closed
Updated: May 15, 2024
Shandong Pharmaceutical Glass Co Ltd
/
Income Statement
/
Income from Continuing Operations

Shandong Pharmaceutical Glass Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Pharmaceutical Glass Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
1066
603658
300888
300832
300595

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Income from Continuing Operations
¥737.7m
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
19%
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Income from Continuing Operations
¥2.1B
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Income from Continuing Operations
¥1.3B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Income from Continuing Operations
¥628.5m
CAGR 3-Years
-45%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Income from Continuing Operations
¥1.7B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Autek China Inc
SZSE:300595
Income from Continuing Operations
¥743.2m
CAGR 3-Years
10%
CAGR 5-Years
27%
CAGR 10-Years
N/A

See Also

What is Shandong Pharmaceutical Glass Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
737.7m CNY

Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Income from Continuing Operations amounts to 737.7m CNY.

What is Shandong Pharmaceutical Glass Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
19%

Over the last year, the Income from Continuing Operations growth was 20%. The average annual Income from Continuing Operations growth rates for Shandong Pharmaceutical Glass Co Ltd have been 12% over the past three years , 18% over the past five years , and 19% over the past ten years .

ALPHA SPREAD
Join more than 137,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.